A patient with acute pulmonary edema is suffering from what pathological change to the lungs?

Background

Definition: Accumulation of blood in the pulmonary vasculature as a result of the inability of the left ventricle to pump blood forward adequately. Acute pulmonary edema, congestive heart failure and cardiogenic shock are a spectrum of diseases and should be considered and managed differently.

Epidemiology:

  • 5 Million patients diagnosed with CHF in the US
  • 500,000 new CHF diagnoses each year in the US
  • Unclear what percentage of these patients will present with acute pulmonary edema (APE)

Causes: Acute myocardial infarction (AMI) is the most common cause of APE but there are a multitude of other causes including acute valvular pathology.

Pathophysiology: Our understanding of the pathophysiology of APE has changed dramatically over the last 70 years. The current model is based on the effects of neurohormones:

  • Primary myocardial injury (AMI) or stress leads to decreased arterial blood pressure and renal perfusion
    A patient with acute pulmonary edema is suffering from what pathological change to the lungs?
  • Decreased arterial blood pressure causes sympathetic activation and release of neurohormones (i.e. norepinephrine).
  • Decreased renal perfusion activates the renin-angiotensin-aldoserone system (RAAS)
  • Increased circulating neurohormones cause peripheral vasoconstriction (increased afterload) and cardiotoxicity leading to secondary myocardial injury
  • Splanchnic vasoconstriction leads to redistribution of blood contributing to increased preload and eventually, pulmonary volume overload

Immediate Management:

NB: Patients with APE have extremely tenuous respiratory status. As such, early management choices (first 10 minutes) determine whether these patients have good or bad outcomes.

Basics: ABCs, IV, O2, Cardiac Monitor, 12-lead EKG and POC Lung Ultrasound

Breathing

  • Severe respiratory distress typically present and increased work of breathing can lead to fatigue as well as worsening cardiac function
  • Apply non-invasive positive pressure ventilation (NIPPV)
    • Multiple effects including decreasing work of breathing and stenting open alveoli during the entire respiratory cycle leading to improved gas exchange.
    • NIPPV has been shown to reduce the need for intubation by decreasing work of breathing (Nava 2003, Bersten 1991)
    • Limited evidence demonstrates an advantage of bilevel positive airway pressure (BPAP) over continuous positive airway pressure (CPAP) (Liesching 2014)

Circulation

  • APE patients will have severely elevated blood pressures resulting from sympathetic activation and resultant vasoconstriction.
  • Despite elevated blood pressures, end organ hypoperfusion occurs due to marked arterial vasoconstriction. This leads to acute kidney injury (AKI), intestinal ischemia, coronary ischemia and brain hypoperfusion.
  • The lungs in a patient with APE are like an overflowing bathtub. We have to simultaneously stop the inflow of blood by turning off the tap (preload reduction) and increase outflow by unclogging the drain (afterload reduction)

12-Lead EKG

  • Obtain an EKG as soon as possible to help identify etiologies of APE with specific indicated interventions.

    A patient with acute pulmonary edema is suffering from what pathological change to the lungs?

    Acute Pulmonary Edema – radpod.com

  • Myocardial ischemia and infarction are common causes of APE that EKG can rapidly identify.
  • Life-threatening tachydysrhythmias may cause APE or occur due to ischemia.

Chest X-Ray (CXR)

  • May be helpful in confirming clinical diagnosis and in ruling out other possible etiologies.
  • Most common finding: bilateral pulmonary congestion

Point of Care Ultrasound (POCUS)

  • Point of Care Ultrasound (POCUS)
    • POCUS is an important diagnostic modality in patients with suspected APE

      A patient with acute pulmonary edema is suffering from what pathological change to the lungs?

      B-Lines Seen on Lung Ultrasound

    • In patients with APE, POCUS will demonstrate the presence of “B-lines”
      • The presence of > 3 B-lines per rib space suggests the presence of interstitial pulmonary fluid.
      • Read More: Lichtenstein’s BLUE Protocol
    • Severe respiratory distress can be caused by a number of etiologies
      • Presenting symptoms and signs overlap
      • Diagnoses may be difficult to differentiate clinically
      • Alternate diagnoses: asthma/COPD exacerbation, pulmonary embolism, pneumothorax
    • Evidence demonstrates that physicians more accurately identify pulmonary edema on lung US than with CXR (Martindale 2012).
    • A recent RCT demonstrated superiority of lung US in determining the final diagnosis of a patient presenting with undifferentiated respiratory distress (Laursen et al. 2014).
    • Additionally, POCUS may identify a ruptured valve causing the patient’s symptoms leading to an alternate management pathway (i.e. cardiovascular surgery for valve repair)

    Read More: US Against the World: Ultrasound in Differentiating COPD from CHF (Boring EM)

Less Useful Treatments

  • Morphine
    • Classic teaching from medical school endorses treatment of APE with “MONA” – Morphine, Oxygen, Nitroglycerin and Aspirin.
    • Retrospective analysis of the Acute Decompensated Heart Failure Registry (ADHERE) database demonstrated an association between the use of morphine and increased mortality and ICU admission rate. (Peacock 2008)
    • Read More: Morphine Kills in Acute Decompensated Heart Failure (REBEL EM)
  • Loop Diuretics (i.e. furosemide)
    • More than 50% of patients presenting in APE do not have volume overload but rather have volume redistribution (Zile 2008, Chaudhry 2007, Fallick 2011).
    • Additionally, many patients with APE and volume overload will also have ESRD making loop diuretics noneffective in eliminating volume.
    • Loop diuretics decrease glomeluar filtration rate (GFR), activate the RAAS, decrease cardiac output and increase afterload early after administration (Marik 2012).

Read More: Furosemide in the Treatment of Acute Pulmonary Edema (emDocs.net)

References:

Nava S et al. Noninvasive ventilation in cardiogenic pulmonary edema – a multicenter randomized trial. Am J Resp Crit Care Med 2003; 168: 1432-7. PMID: 12958051

Bersten AD et al. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. NEJM 1991; 325 (26): 1825-30. PMID: 1961221

Liesching T et al. Randomized trial of bilevel versus continuous positive airway pressure for acute pulmonary edema. J Emerg Med 2014; 46(1): 130-40. PMID: 24071031

Lichtenstein DA, Meziere GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: The BLUE protocol. Chest 2008; 134: 117-25. PMID: 18403664

Martindale JL et al. Diagnosing pulmonary edema: lung ultrasound versus chest radiography. Eur J Emerge Med 2012. PMID: 23263648

Laursen CB et al. Point-of-care ultrasonography in patients admitted with respiratory symptoms: a single-blind, randomised controlled trial. Lancet Respir Med 2014; 2: 638-46. PMID: 24998674

Bussmann W, Schupp D. Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema. Am J Card 1978; 41: 931-936. PMID: 417614

Hamilton RJ et al. Rapid Improvement of acute pulmonary edema with sublingual captopril. Acad Emerg Med 1996; 3: 205-12. PMID: 8673775

Haude M et al. Sublingual administration of captopril versus nitroglycerin in patients with severe congestive heart failure. Intl J Card 1990; 27: 351-9. PMID: 2112516

Peacock WF et al. Morphine and Outcomes in Acute Decompensated Heart Failure: An ADHERE Analysis. Emerg Med J 2008; 25: 205 – 209. PMID: 18356349

Zile MR et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008; 118: 1433-41. PMID: 18794390

Chaudhry S et al. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007;116:1549 –54. PMID: 17846286

Fallick C et al. Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation. Circ Heart Fail 2011; 4: 669-75. PMID: 21934091

Marik PE, Flemmer M. Narrative review: the management of acute decompensated heart failure. J Intensive Care Med 2012; 27: 343-53. PMID: 21616957

What happens to the lungs during pulmonary edema?

Pulmonary edema is a condition caused by too much fluid in the lungs. This fluid collects in the many air sacs in the lungs, making it difficult to breathe. In most cases, heart problems cause pulmonary edema.

What is the most common cause of acute pulmonary oedema?

The most common causes of acute pulmonary oedema include myocardial ischaemia, arrhythmias (e.g. atrial fibrillation), acute valvular dysfunction and fluid overload. Other causes include pulmonary embolus, anaemia and renal artery stenosis.

Can pulmonary edema cause acute respiratory failure?

Pulmonary edema can be a result of several conditions, including congestive heart failure, pneumonia, and sepsis. In addition to causing symptoms such as cough, wheezing, chest pain, and excessive sweating, pulmonary edema can result in severe breathing difficulties and may be fatal without proper treatment.

What is the main complaint of patient with acute pulmonary edema?

Acute pulmonary edema will have[11]: Excessive shortness of breath worsening on exertion or lying down. A feeling of the sinking of heart and drowning/anxiety worsening on lying down. Gasping for breath.